1-iodo-3-phenylbenzene | CAS:20442-79-9

We serve 1-iodo-3-phenylbenzene CAS:20442-79-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-iodo-3-phenylbenzene

Chemical Name:1-iodo-3-phenylbenzene
CAS.NO:20442-79-9
Synonyms:1,1'-Biphenyl,3-iodo
3-Biphenyliodid
3-iodobiphenyl
m-Iodobiphenyl
3-Jod-biphenyl
Molecular Formula:C12H9I
Molecular Weight:280.10400
 
Physical and Chemical Properties:
Density:1.584
Boiling point:341.6ºC
Flash point:154.7ºC
Index of Refraction:1.64
 
Specification:
Appearance:Light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 1-iodo-3-phenylbenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Jod-biphenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-iodobiphenyl Use and application,3-Biphenyliodid technical grade,usp/ep/jp grade.


Related News: TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment.4-Bromo-3-fluorobenzotrifluoride manufacturer At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.1,4'-bipiperidine supplier As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.5-Bromo-2-iodopyridine vendor A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.